Related references
Note: Only part of the references are listed.Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis: results of a pilot study
Ayman Yosry et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
Paolo Caraceni et al.
LANCET (2018)
Insufficient evidence of benefit regarding mortality due to albumin substitution in HCC-free cirrhotic patients undergoing large volume paracentesis
Fabian Kuetting et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations
Marinos Pericleous et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012
Bruce A. Runyon
HEPATOLOGY (2013)
The Combination of Octreotide and Midodrine Is Not Superior to Albumin in Preventing Recurrence of Ascites After Large-Volume Paracentesis
Khurram Bari et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Albumin infusion in patients undergoing large-volume paracentesis: A meta-analysis of randomized trials
Mauro Bernardi et al.
HEPATOLOGY (2012)
Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration
Monica Guevara et al.
LIVER INTERNATIONAL (2010)
Randomized trial comparing human albumin and hydroxyethyl starch 6% as plasma expanders for treatment of patients with liver cirrhosis and tense ascites following large volume paracentesis
Ehab E. Abdel-Khalek et al.
Arab Journal of Gastroenterology (2010)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Midodrine Versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: A randomized pilot study
Virendra Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Prevention of paracentesis-induced circulatory dysfunction:: midodrine vs albumin.: A randomized pilot study
Beate Appenrodt et al.
LIVER INTERNATIONAL (2008)
Hyponatremia and mortality among patients on the liver-transplant waiting list
W. Ray Kim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Guidelines on the management of ascites in cirrhosis
K. P. Moore et al.
GUT (2006)
Spontaneous bacterial peritonitis in cirrhotic patients: Is prophylactic propranolol therapy beneficial?
E Cholongitas et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid:: A randomised controlled pilot trial
R Moreau et al.
LIVER INTERNATIONAL (2006)
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
G D'Amico et al.
JOURNAL OF HEPATOLOGY (2006)
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: A randomized study
V Singh et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites
J Sola-Vera et al.
HEPATOLOGY (2003)
Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study
R Moreau et al.
GUT (2002)
Share Paper
